157 related articles for article (PubMed ID: 3009012)
1. Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine.
Griffiths JD; Stark RJ; Ding JC; Cooper IA
Cancer Treat Rep; 1986 Apr; 70(4):519-21. PubMed ID: 3009012
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the additive potential of teniposide and vincristine in non-Hodgkin's lymphoma. Australian and New Zealand Lymphoma Group.
Cancer Treat Rep; 1986 Aug; 70(8):985-90. PubMed ID: 2873890
[TBL] [Abstract][Full Text] [Related]
3. Clinical and electrophysiological studies in vincristine induced neuropathy.
Pal PK
Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
[TBL] [Abstract][Full Text] [Related]
4. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the use of teniposide and vincristine in combination chemotherapy for non-Hodgkin's lymphoma.
Cancer Treat Rep; 1982 Jan; 66(1):49-55. PubMed ID: 7053265
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxicity and efficacy of combined vinca alkaloids in breast cancer.
Stewart DJ; Maroun JA; Lefebvre B; Heringer R
Cancer Treat Rep; 1986 May; 70(5):571-3. PubMed ID: 3011256
[TBL] [Abstract][Full Text] [Related]
7. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
Verstappen CC; Koeppen S; Heimans JJ; Huijgens PC; Scheulen ME; Strumberg D; Kiburg B; Postma TJ
Neurology; 2005 Mar; 64(6):1076-7. PubMed ID: 15781834
[TBL] [Abstract][Full Text] [Related]
8. Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy.
Ozyurek H; Turker H; Akbalik M; Bayrak AO; Ince H; Duru F
Pediatr Hematol Oncol; 2007 Sep; 24(6):447-52. PubMed ID: 17710662
[TBL] [Abstract][Full Text] [Related]
9. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.
Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS
Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399
[TBL] [Abstract][Full Text] [Related]
10. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
[No Abstract] [Full Text] [Related]
11. [A case of non-Hodgkin's lymphoma presenting optic neuropathy induced by vincristine].
Hashimoto K; Akagawa S; Takashimizu I; Tamura A; Kubota T; Murota N; Tanoue M; Momoi H; Mitsunaga K
Nihon Naika Gakkai Zasshi; 1984 Aug; 73(8):1217-21. PubMed ID: 6512355
[No Abstract] [Full Text] [Related]
12. [Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease].
Uno S; Katayama K; Dobashi N; Hirano A; Ogihara A; Yamazaki H; Usui N; Kobayashi T; Inoue K; Kuraishi Y
Rinsho Ketsueki; 1999 May; 40(5):414-9. PubMed ID: 10390891
[TBL] [Abstract][Full Text] [Related]
13. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA
Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
[TBL] [Abstract][Full Text] [Related]
14. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies.
Chaudhry V; Rowinsky EK; Sartorius SE; Donehower RC; Cornblath DR
Ann Neurol; 1994 Mar; 35(3):304-11. PubMed ID: 7907208
[TBL] [Abstract][Full Text] [Related]
15. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
16. Experience with vincristine--associated neurotoxicity.
Othieno-Abinya NA; Nyabola LO
East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264
[TBL] [Abstract][Full Text] [Related]
17. Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma.
Wanschitz J; Dichtl W; Budka H; Löscher WN; Boesch S
Muscle Nerve; 2006 Oct; 34(4):494-8. PubMed ID: 16671108
[TBL] [Abstract][Full Text] [Related]
18. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced refractory lymphoma with teniposide and lomustine.
Grossberg H; Opfell R; Glick J; Bakemeier R; Schnetzer G; Muggia F
Cancer Treat Rep; 1987 Feb; 71(2):215-6. PubMed ID: 3802119
[No Abstract] [Full Text] [Related]
20. A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.
Davidson KL; Devaney MB; Tighe JE; Rogers SY; Dunlop DJ; Mackie MJ; Thomas RV; Johnson PR;
Haematologica; 2003 Dec; 88(12):1366-71. PubMed ID: 14687989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]